Announcement on Implementation Results of Share Repurchase
Filed with SSE · · 5 pages · Chinese
Eyebright Medical Technology (Beijing) Co., Ltd. on 6ix
Earlier from Eyebright Medical Technology (Beijing)
- Announcement on the Voluntary Disclosure of the Phakic Intraocular Lens Being Approved for Marketing through the Special Review Procedure for Innovative Medical Devices
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on the Completion of the Company's Shareholding Increase Plan by Controlling Shareholders, Actual Controllers, Chairman and General Manager, Some Directors, and Senior Management and Results of Shareholding Increase
- Announcement on Resolution of the 16th Meeting of the 2nd Board of Directors
- Announcement on Share Reduction Plan for Shareholders with Over 5% Shares
Later from Eyebright Medical Technology (Beijing)
- Announcement on the Release of Pledge of Shares by Shareholders
- Announcement on Diluted Immediate Return, Remedial Measures, and Related Entity Commitments for Issuance of Shares to Specific Objects by Summary Procedure (Second Revised)
- Announcement on the Acceptance of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange
- Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Share Reduction
- Announcement on Approval of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange in 2024
Follow Eyebright Medical Technology (Beijing) into a list and get an email when it puts out news.
Follow Eyebright Medical Technology (Beijing)